Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Ontaneda, MD, PhD
The Cleveland Clinic
Principal Investigator - Nancy Sicotte, MD
Cedars-Sinai Medical Center
Principal Investigator - Pascal Sati, PhD
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Michael'S Hospital of Unity Health Toronto
Toronto, Ontario, Canada
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of Southern California
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- the University of Texas at Austin
Austin, Texas, United States
- University of Vermont
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jun 2020
- Primary completion
- 31 Jan 2027
- Completion
- 31 Jan 2027
- Last update posted
- 2 Oct 2025
- Registered enrollment
- 420
- Registry id
- NCT04495556
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.